IBM Watson Health is now Merative

IBM and Francisco Partners announced a definitive agreement under which Francisco Partners acquired health data and analytics assets from IBM that were part of the Watson Health business. When the transaction closed, Merative became a standalone company. All future information regarding the Watson Health products will be available from www.merative.com (link resides outside ibm.com).  

When you access the non-IBM Web sites, even though they may contain the IBM logo and content regarding IBM's products and services, such Web sites are independent of IBM and IBM makes no representations or warranties regarding the content and has no control over the operation of such non-IBM Web sites. In addition, a link to a non-IBM Web site does not mean that IBM endorses that Web site or has any responsibility for the use of such Web site.

Product families offered by Merative include:

Health Insights *
Analyze, visualize and report complex data with an integrated data warehouse and analytics portfolio.

Micromedex *
Support informed, evidence-based clinical decision making, drug supply chain management and patient education.

Social Program Management *
Manage health and social programs, including eligibility, benefit management and family support programs.

Zelta (formerly Clinical Development) *
Accelerate clinical trials with a unified, cloud-based clinical data management system.

Merge *
Build an enterprise imaging environment with a scalable, AI-enabled infrastructure that centralizes data.

MarketScan *
Gain insights from integrated, patient-level claims data from 273 million unique patient lives.

Continue to merative.com *

* link resides outside ibm.com